Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADBE vs MRNA✓SelectedUSD · MRNAADBE vs MRNA performance historyLatest closeAs of-1.79%11/20
Stock and ETF performance explorer

ADBE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-30.3%
MRNA return
+697.5%
Excess return
-727.9%
Maximum drawdown
-45.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.8%-2.2%+0.4%-1.8%
7D-10.4%-12.7%+2.3%-10.3%
30D-14.6%-20.7%+6.0%-14.4%
3M-20.0%+46.3%-66.3%-20.7%
6M-14.1%+305.2%-319.3%-16.9%
YTD-37.8%+561.2%-599.0%-40.8%
1Y-30.3%+772.1%-802.4%-37.5%
All-30.3%+697.5%-727.9%-37.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling